Polycystic Ovary Syndrome (PCOS) Treatment Market
Polycystic Ovary Syndrome (PCOS) Treatment Market Study by Oral Contraceptives, Insulin Sensitizing Agents, Antidepressants, Ornithine Decarboxylase Inhibitors, and Others from 2024 to 2034
Analysis of Polycystic Ovary Syndrome (PCOS) Treatment Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
- FACT10043MR
- 17 Apr 2024
- Healthcare
- 170 Pages
- 25 Tables
- 132 Figures
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Key Market Trends
- 4. Key Success Factors
- 5. Market Background
- 6. Global Market Volume (Units) Analysis 2018 to 2023 and Forecast, 2024 to 2034
- 7. Global Market - Pricing Analysis
- 8. Global Market Value Analysis 2018 to 2023 and Forecast, 2024 to 2034
- 9. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Drug Class
- 9.1. Oral Contraceptives
- 9.2. Insulin-Sensitizing Agents
- 9.3. Antidepressants
- 9.4. Ornithine Decarboxylase Inhibitors
- 9.5. Aromatase Inhibitors & SERMs
- 10. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Distribution Channel
- 10.1. Hospital Pharmacies
- 10.2. Drug Stores/OTC
- 10.3. e-Commerce
- 11. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Region
- 11.1. North America
- 11.2. Latin America
- 11.3. Europe
- 11.4. East Asia
- 11.5. South Asia
- 11.6. Oceania
- 11.7. Middle East and Africa (MEA)
- 12. North America Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 13. Latin America Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 14. Europe Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 15. South Asia Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 16. East Asia Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 17. Oceania Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 18. Middle East and Africa Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 19. Key and Emerging Countries Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 20. Market Structure Analysis
- 21. Competition Analysis
- 21.1. Sanofi
- 21.2. Novartis AG
- 21.3. Teva Pharmaceutical Industries Limited
- 21.4. Addex Therapeutics Ltd.
- 21.5. Bristol Myers Squibb Co.
- 21.6. Ferring Pharmaceuticals
- 21.7. Crinetics Pharmaceuticals
- 21.8. AstraZeneca Plc
- 21.9. Aphena Pharma Solutions Tennessee, Inc.
- 21.10. Lupin Pharmaceuticals
- 21.11. Sun Pharmaceutical Industries Ltd.
- 22. Assumptions and Acronyms Used
- 23. Research Methodology
List Of Table
Table 01: Global Market Volume (‘000 Units) Analysis and Opportunity Assessment 2018 to 2034, By Drug Class
Table 02: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Drug Class
Table 03: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Distribution Channel
Table 04: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Region
Table 05: North America Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 06: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Drug Class
Table 07: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Distribution Channel
Table 08: Latin America Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 09: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Drug Class
Table 10: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Distribution Channel
Table 11: Europe Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 12: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Drug Class
Table 13: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Distribution Channel
Table 14: South Asia Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 15: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Drug Class
Table 16: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Distribution Channel
Table 17: East Asia Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 18: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Drug Class
Table 19: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Distribution Channel
Table 20: Oceania Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 21: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Drug Class
Table 22: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Distribution Channel
Table 23: Middle East and Africa Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 24: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Drug Class
Table 25: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Distribution Channel
List Of Figures
Figure 01: Global Market Volume (in 000' Units) Analysis, 2018 to 2023
Figure 02: Global Market Volume Forecast (in 000' Units), 2024 to 2034
Figure 03: Pricing Analysis (US$) Per Drug Class, By Region, 2023
Figure 04: Pricing Analysis (US$) Per Drug Class, By Region, 2023
Figure 05: Global Market Value Analysis (US$ Mn), 2018 to 2023
Figure 06: Global Market Value Forecast (US$ Mn), 2024 to 2034
Figure 07: Global Market Absolute $ Opportunity, 2024 to 2034
Figure 08: Global Market Share Analysis (%), By Drug Class, 2024 to 2034
Figure 09: Global Market Y-o-Y Analysis (%), By Drug Class, 2024 to 2034
Figure 10: Global Market Attractiveness Analysis by Drug Class, 2024 to 2034
Figure 11: Global Market Share Analysis (%), By Distribution Channel, 2024 to 2034
Figure 12: Global Market Y-o-Y Analysis (%), By Distribution Channel, 2024 to 2034
Figure 13: Global Market Attractiveness Analysis by Distribution Channel, 2024 to 2034
Figure 14: Global Market Share Analysis (%), By Region, 2024 to 2034
Figure 15: Global Market Y-o-Y Analysis (%), By Region, 2024 to 2034
Figure 16: Global Market Attractiveness Analysis by Region, 2024 to 2034
Figure 17: North America Market Value Share, By Drug Class, 2024 (E)
Figure 18: North America Market Value Share, By Distribution Channel, 2024 (E)
Figure 19: North America Market Value Share, By Country, 2024 (E)
Figure 20: North America Market Value Analysis (US$ Mn), 2018 to 2023
Figure 21: North America Market Value Forecast (US$ Mn), 2024 to 2034
Figure 22: North America Market Attractiveness Analysis by Drug Class, 2024 to 2034
Figure 23: North America Market Attractiveness Analysis by Distribution Channel, 2024 to 2034
Figure 24: North America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 25: Latin America Market Value Share, By Drug Class, 2024 (E)
Figure 26: Latin America Market Value Share, By Distribution Channel, 2024 (E)
Figure 27: Latin America Market Value Share, By Country, 2024 (E)
Figure 28: Latin America Market Value Analysis (US$ Mn), 2018 to 2023
Figure 29: Latin America Market Value Forecast (US$ Mn), 2024 to 2034
Figure 30: Latin America Market Attractiveness Analysis by Drug Class, 2024 to 2034
Figure 31: Latin America Market Attractiveness Analysis by Distribution Channel, 2024 to 2034
Figure 32: Latin America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 33: Europe Market Value Share, By Drug Class, 2024 (E)
Figure 34: Europe Market Value Share, By Distribution Channel, 2024 (E)
Figure 35: Europe Market Value Share, By Country, 2024 (E)
Figure 36: Europe Market Value Analysis (US$ Mn), 2018 to 2023
Figure 37: Europe Market Value Forecast (US$ Mn), 2024 to 2034
Figure 38: Europe Market Attractiveness Analysis by Drug Class, 2024 to 2034
Figure 39: Europe Market Attractiveness Analysis by Distribution Channel, 2024 to 2034
Figure 40: Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 41: South Asia Market Value Share, By Drug Class, 2024 (E)
Figure 42: South Asia Market Value Share, By Distribution Channel, 2024 (E)
Figure 43: South Asia Market Value Share, By Country, 2024 (E)
Figure 44: South Asia Market Value Analysis (US$ Mn), 2018 to 2023
Figure 45: South Asia Market Value Forecast (US$ Mn), 2024 to 2034
Figure 46: South Asia Market Attractiveness Analysis by Drug Class, 2024 to 2034
Figure 47: South Asia Market Attractiveness Analysis by Distribution Channel, 2024 to 2034
Figure 48: South Asia Market Attractiveness Analysis by Country, 2024 to 2034
Figure 49: East Asia Market Value Share, By Drug Class, 2024 (E)
Figure 50: East Asia Market Value Share, By Distribution Channel, 2024 (E)
Figure 51: East Asia Market Value Share, By Country, 2024 (E)
Figure 52: East Asia Market Value Analysis (US$ Mn), 2018 to 2023
Figure 53: East Asia Market Value Forecast (US$ Mn), 2024 to 2034
Figure 54: East Asia Market Attractiveness Analysis by Drug Class, 2024 to 2034
Figure 55: East Asia Market Attractiveness Analysis by Distribution Channel, 2024 to 2034
Figure 56: East Asia Market Attractiveness Analysis by Country, 2024 to 2034
Figure 57: Oceania Market Value Share, By Drug Class, 2024 (E)
Figure 58: Oceania Market Value Share, By Distribution Channel, 2024 (E)
Figure 59: Oceania Market Value Share, By Country, 2024 (E)
Figure 60: Oceania Market Value Analysis (US$ Mn), 2018 to 2023
Figure 61: Oceania Market Value Forecast (US$ Mn), 2024 to 2034
Figure 62: Oceania Market Attractiveness Analysis by Drug Class, 2024 to 2034
Figure 63: Oceania Market Attractiveness Analysis by Distribution Channel, 2024 to 2034
Figure 64: Oceania Market Attractiveness Analysis by Country, 2024 to 2034
Figure 65: Middle East and Africa Market Value Share, By Drug Class, 2024 (E)
Figure 66: Middle East and Africa Market Value Share, By Distribution Channel, 2024 (E)
Figure 67: Middle East and Africa Market Value Share, By Country, 2024 (E)
Figure 68: Middle East and Africa Market Value Analysis (US$ Mn), 2018 to 2023
Figure 69: Middle East and Africa Market Value Forecast (US$ Mn), 2024 to 2034
Figure 70: Middle East and Africa Market Attractiveness Analysis by Drug Class, 2024 to 2034
Figure 71: Middle East and Africa Market Attractiveness Analysis by Distribution Channel, 2024 to 2034
Figure 72: Middle East and Africa Market Attractiveness Analysis by Country, 2024 to 2034
Figure 73: UNITED STATES Market Value Analysis (US$ Mn), 2024 & 2034
Figure 74: UNITED STATES Market Value Share, By Drug Class, 2024 (E)
Figure 75: UNITED STATES Market Value Share, By Distribution Channel, 2024 (E)
Figure 76: Canada Market Value Analysis (US$ Mn), 2024 & 2034
Figure 77: Canada Market Value Share, By Drug Class, 2024 (E)
Figure 78: Canada Market Value Share, By Distribution Channel, 2024 (E)
Figure 79: Mexico Market Value Analysis (US$ Mn), 2024 & 2034
Figure 80: Mexico Market Value Share, By Drug Class, 2024 (E)
Figure 81: Mexico Market Value Share, By Distribution Channel, 2024 (E)
Figure 82: Brazil Market Value Analysis (US$ Mn), 2024 & 2034
Figure 83: Brazil Market Value Share, By Drug Class, 2024 (E)
Figure 84: Brazil Market Value Share, By Distribution Channel, 2024 (E)
Figure 85: UNITED KINGDOM Market Value Analysis (US$ Mn), 2024 & 2034
Figure 86: UNITED KINGDOM Market Value Share, By Drug Class, 2024 (E)
Figure 87: UNITED KINGDOM Market Value Share, By Distribution Channel, 2024 (E)
Figure 88: Germany Market Value Analysis (US$ Mn), 2024 & 2034
Figure 89: Germany Market Value Share, By Drug Class, 2024 (E)
Figure 90: Germany Market Value Share, By Distribution Channel, 2024 (E)
Figure 91: France Market Value Analysis (US$ Mn), 2024 & 2034
Figure 92: France Market Value Share, By Drug Class, 2024 (E)
Figure 93: France Market Value Share, By Distribution Channel, 2024 (E)
Figure 94: Italy Market Value Analysis (US$ Mn), 2024 & 2034
Figure 95: Italy Market Value Share, By Drug Class, 2024 (E)
Figure 96: Italy Market Value Share, By Distribution Channel, 2024 (E)
Figure 97: Spain Market Value Analysis (US$ Mn), 2024 & 2034
Figure 98: Spain Market Value Share, By Drug Class, 2024 (E)
Figure 99: Spain Market Value Share, By Distribution Channel, 2024 (E)
Figure 100: Russia Market Value Analysis (US$ Mn), 2024 & 2034
Figure 101: Russia Market Value Share, By Drug Class, 2024 (E)
Figure 102: Russia Market Value Share, By Distribution Channel, 2024 (E)
Figure 103: China Market Value Analysis (US$ Mn), 2024 & 2034
Figure 104: China Market Value Share, By Drug Class, 2024 (E)
Figure 105: China Market Value Share, By Distribution Channel, 2024 (E)
Figure 106: Japan Market Value Analysis (US$ Mn), 2024 & 2034
Figure 107: Japan Market Value Share, By Drug Class, 2024 (E)
Figure 108: Japan Market Value Share, By Distribution Channel, 2024 (E)
Figure 109: South Korea Market Value Analysis (US$ Mn), 2024 & 2034
Figure 110: South Korea Market Value Share, By Drug Class, 2024 (E)
Figure 111: South Korea Market Value Share, By Distribution Channel, 2024 (E)
Figure 112: India Market Value Analysis (US$ Mn), 2024 & 2034
Figure 113: India Market Value Share, By Drug Class, 2024 (E)
Figure 114: India Market Value Share, By Distribution Channel, 2024 (E)
Figure 115: ASEAN Market Value Analysis (US$ Mn), 2024 & 2034
Figure 116: ASEAN Market Value Share, By Drug Class, 2024 (E)
Figure 117: ASEAN Market Value Share, By Distribution Channel, 2024 (E)
Figure 118: Australia Market Value Analysis (US$ Mn), 2024 & 2034
Figure 119: Australia Market Value Share, By Drug Class, 2024 (E)
Figure 120: Australia Market Value Share, By Distribution Channel, 2024 (E)
Figure 121: New Zealand Market Value Analysis (US$ Mn), 2024 & 2034
Figure 122: New Zealand Market Value Share, By Drug Class, 2024 (E)
Figure 123: New Zealand Market Value Share, By Distribution Channel, 2024 (E)
Figure 124: GCC Countries Market Value Analysis (US$ Mn), 2024 & 2034
Figure 125: GCC Countries Market Value Share, By Drug Class, 2024 (E)
Figure 126: GCC Countries Market Value Share, By Distribution Channel, 2024 (E)
Figure 127: Turkey Market Value Analysis (US$ Mn), 2024 & 2034
Figure 128: Turkey Market Value Share, By Drug Class, 2024 (E)
Figure 129: Turkey Market Value Share, By Distribution Channel, 2024 (E)
Figure 130: South Africa Market Value Analysis (US$ Mn), 2024 & 2034
Figure 131: South Africa Market Value Share, By Drug Class, 2024 (E)
Figure 132: South Africa Market Value Share, By Distribution Channel, 2024 (E)
Polycystic Ovary Syndrome (PCOS) Treatment Market